BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37236806)

  • 1. Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Geeraerts T; Guilbeau-Frugier C; Garcia C; Memier V; Raposo N; Bonneville F; Gales C; Darcourt J; Voisin S; Ribes A; Piel-Julian M; Bounes F; Albucher JF; Roux FE; Izopet J; Telmon N; Olivot JM; Sié P; Bauer J; Payrastre B; Liblau RS
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37236806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
    van de Munckhof A; Lindgren E; Kleinig TJ; Field TS; Cordonnier C; Krzywicka K; Poli S; Sánchez van Kammen M; Borhani-Haghighi A; Lemmens R; Scutelnic A; Ciccone A; Gattringer T; Wittstock M; Dizonno V; Devroye A; Elkady A; Günther A; Cervera A; Mengel A; Chew BLA; Buck B; Zanferrari C; Garcia-Esperon C; Jacobi C; Soriano C; Michalski D; Zamani Z; Blacquiere D; Johansson E; Cuadrado-Godia E; Vuillier F; Bode FJ; Caparros F; Maier F; Tsivgoulis G; Katzberg HD; Duan J; Burrow J; Pelz J; Mbroh J; Oen J; Schouten J; Zimmermann J; Ng K; Garambois K; Petruzzellis M; Carvalho Dias M; Ghiasian M; Romoli M; Miranda M; Wronski M; Skjelland M; Almasi-Dooghaee M; Cuisenier P; Murphy S; Timsit S; Coutts SB; Schönenberger S; Nagel S; Hiltunen S; Chatterton S; Cox T; Bartsch T; Shaygannejad V; Mirzaasgari Z; Middeldorp S; Levi MM; Kremer Hovinga JA; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; Aguiar de Sousa D; Ferro JM; Coutinho JM;
    Stroke; 2022 Oct; 53(10):3206-3210. PubMed ID: 36082668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced immune thrombotic thrombocytopenia with atypical vein thrombosis: Implications for clinical practice.
    Zamboni P; Scerrati A; Sessa F; Pomara C; Mannucci PM
    Phlebology; 2022 Apr; 37(3):180-187. PubMed ID: 35068258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced immune thrombotic thrombocytopenia.
    Kanack AJ; Padmanabhan A
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101381. PubMed ID: 36494147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
    van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
    Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis.
    Saleh M; Zimmermann J; Lehnen NC; Pötzsch B; Weller JM
    J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106311. PubMed ID: 35093626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced COVID-19 mimicry syndrome.
    Kowarz E; Krutzke L; Külp M; Streb P; Larghero P; Reis J; Bracharz S; Engler T; Kochanek S; Marschalek R
    Elife; 2022 Jan; 11():. PubMed ID: 35084333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report.
    Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL
    Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
    Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines.
    Hwang J; Lee SB; Lee SW; Lee MH; Koyanagi A; Jacob L; Tizaoui K; Yon DK; Shin JI; Smith L
    J Autoimmun; 2021 Aug; 122():102681. PubMed ID: 34139631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 vaccine-induced cerebral venous thrombosis.
    Ciccone A
    Eur J Intern Med; 2021 Jul; 89():19-21. PubMed ID: 34090750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.
    Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE
    J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-Inducted Thrombotic Thrombocytopenia and Covid-19 Vaccines: Case Series.
    Trajkovska EL; Mitevska I; Bosevski M; Nastevska CEG; Chelikikj A; Gjorgjievski A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2022 Apr; 43(1):49-55. PubMed ID: 35451293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.